CAPTRUST FINANCIAL ADVISORS
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1512024
RALEIGH, NC
Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,330,361
+$8,072,180 QoQ
Shares Held
32,092
+132.5% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 80.2318334787486.ToString("F0")%
Shared 0.ToString("F0")%
None 19.768166521251402.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPTRUST FINANCIAL ADVISORS holds $130,226,430 across 94 Biotechnology names. VRTX ranks #2 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,502 | $29,748,185 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
32,092 | $14,330,361 | |
| 3 | EXEL |
Exelixis, Inc.
|
312,296 | $13,394,375 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
121,088 | $7,825,917 | |
| 5 | CELC |
Celcuity Inc.
|
61,068 | $6,970,301 | |
| 6 | RPRX |
Royalty Pharma plc
|
143,760 | $6,896,167 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
29,900 | $5,969,535 | |
| 8 | INCY |
Incyte Corp
|
53,555 | $5,040,596 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,330,361 | 32,092 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,258,181 | 13,804 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,728,661 | 12,074 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $5,926,502 | 13,312 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $6,559,614 | 13,530 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,851,729 | 12,048 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,701,337 | 14,409 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,609,889 | 14,102 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $6,959,030 | 16,648 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,995,931 | 22,109 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,559,767 | 18,864 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $7,416,151 | 21,074 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $6,473,428 | 20,546 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,629,477 | 19,494 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $5,651,820 | 19,520 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $5,762,605 | 20,450 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $5,072,734 | 19,438 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,664,245 | 16,686 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,500,464 | 19,298 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,148,049 | 15,613 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,027,174 | 4,780 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $395,396 | 1,673 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,254,745 | 4,611 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $1,150,788 | 3,964 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $408,322 | 1,716 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||